Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services

March 13, 2024 updated by: Duygu Sonmez Duzkaya, Tarsus University

Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services On Insertion Success, Duration Of Stay, And Development Of Complications: A Randomized Controlled Study

The study was conducted as a randomized controlled experimental research to examine the effects of open and closed system peripheral catheters on the success of insertion, duration of stay, and development of complications in children aged 1-18 years in pediatric services. The population of the study consisted of children admitted to the Pediatric Services of the Istanbul Faculty of Medicine, and the sample included a total of N=80 children who met the sample criteria and underwent catheter insertion between May 2023 and October 2023. The sample was divided into two groups: closed system peripheral venous catheter group (n=40) and open system peripheral venous catheter group (n=40). The data of the study were collected using a Data Collection Form, Peripheral Venous Catheter Monitoring Form, Visual Infusion Phlebitis Detection Scale, and Pediatric Peripheral Intravenous Infiltration Scale

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study was conducted as a randomized controlled experimental research to determine the impact of open and closed system peripheral catheters on the success of insertion, duration of stay, and the development of complications (infiltration, phlebitis) in children aged 1-18 years.

Location and Characteristics of the Study:

The research data were collected from pediatric patients in the Department of Pediatric Health and Diseases at Istanbul University Istanbul Faculty of Medicine. The pediatric services within the Department include Gastrohepatology, Neurology, Nutrition and Metabolism, Cardiology, Allergy and Immunology, Nephrology, Rheumatology, Endocrinology, and Chest Diseases, comprising a total of 47 service beds.

Study Population and Sample:

The study population consisted of children admitted to the pediatric services of Istanbul University Istanbul Faculty of Medicine between May 2023 and October 2023. The sample size was determined based on literature findings (Boztepe and Abusfia, 2015), considering a type I error rate of 0.05, a test power of 0.91 (α= 0.05, 1-β= 0.95). The minimum sample size for each group was calculated as 66 (n=33). However, to mitigate the possibility of losing cases, a total sample size of 80 patients was determined, with 40 patients in each group. Therefore, 40 patients would constitute the open system catheter group, and 40 patients would form the closed system catheter group. The selection of the sample was carried out through simple randomization based on predefined criteria for grouping the children.

Randomization:

In the study, there are two groups: the study group using closed system peripheral catheters and the control group receiving the routine procedure of the clinic with open system peripheral catheters. Children meeting the inclusion criteria were assigned to groups through a randomization process.

Subsequently, whenever a child meeting the inclusion criteria presented to the pediatric service, a nurse working in the unit, other than the researcher, asked the child to randomly select a piece of paper from a bag. If the paper indicated "control group," the child was assigned to the control group; if it indicated "study group," the child was assigned to the study group.

This randomization method, utilizing a simple and practical approach with the use of paper lots from a bag, ensures that each eligible child has an equal chance of being assigned to either the control or study group. The process helps minimize bias and ensures a more balanced distribution of characteristics across the groups, contributing to the reliability of the study results.

Data Collection:

In the pediatric service where the research was conducted, peripheral venous access and care for children were carried out by nurses using an open system catheter. The control group in this study consisted of the open system catheter group.

Data collection was performed in 6 stages:

Stage: Before the data collection process, a pilot application was conducted with 10 children to assess the suitability of the forms used in the research. Final adjustments were made to the forms after the pilot application.

Stage: Children included in the sample (aged 6 and older) and their parents were informed about the research, and verbal and written consents (informed consent) were obtained.

Stage: Patients meeting the sample selection criteria were randomly and equally distributed into two groups using the randomization method (1st group: control group with open system peripheral catheter application (n=40), 2nd group: study group with closed system peripheral catheter application (n=40)). It was ensured that the parents of children in both groups were present.

Stage: Before the procedure, the researcher filled out the "Patient Identification Form" for all children in the groups.

Stage: According to the group to which the child belonged, the researcher applied the "Peripheral Catheter Insertion and Removal Protocol." The protocol included the following steps:

Hands were washed, and necessary materials (gloves, cotton, an appropriately sized catheter for the child, 0.5% chlorhexidine-containing 70% alcohol, transparent drape, venous valve, saline solution, syringe) were prepared.

The area for catheter insertion was selected (upper extremity veins). Using aseptic technique, the catheter was inserted using the appropriate method (gloves were worn, the catheter area was wiped three times with a solution of 2% chlorhexidine-containing 70% alcohol, and it was allowed to dry; the cleaned area was not touched after wiping).

After inserting the catheter, it was secured using a transparent drape for easy observation.

For children with open system peripheral catheters, a venous valve was attached after catheter insertion to reduce movement of the catheter.

Catheter dressing was changed if there was moisture, looseness, or noticeable contamination.

Stage: After the insertion of the peripheral venous catheter (PVC), children were monitored daily using the "Daily Monitoring Form" until 48 hours after removal.

Data Analysis:

The data obtained in the research were analyzed using the Statistical Package for Social Sciences (SPSS) 22.0 program. Normal distribution analysis was conducted, and it was determined that the data did not follow a normal distribution. Therefore, non-parametric tests were employed for the analyses.

For qualitative variables, frequency and percentage calculations were performed.

For quantitative variables, mean, standard deviation, and median tests were conducted.

Categorical variables were compared using the Chi-square test, while quantitative variables were compared using the Mann-Whitney U test.

A significance level of p<0.05 was considered in the analyses. This means that statistically significant differences were considered when the p-value was below 0.05. This value represents the significance level used to determine differences between various groups in the study.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Mersin, Turkey, 33400
        • Tarsus University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Being between 1 and 18 years of age,

    • Having a catheter requirement for at least 72 hours,
    • The catheter being inserted in the admitting service,
    • Catheters not being inserted under emergency conditions,
    • Absence of other catheters (central venous, arterial, PICC line, etc.),
    • Body temperature not exceeding 38°C,
    • Absence of skin issues in the catheter area,
    • Not undergoing chemotherapy treatment,
    • The catheter being inserted in the upper extremity,
    • Willingness to voluntarily participate in the study.

Exclusion Criteria:

  • Being under 1 year of age or over 18 years,
  • Having a catheter requirement of less than 72 hours,
  • Peripheral catheters being inserted under emergency conditions,
  • Presence of other catheters in the child (central venous, arterial, PICC line, etc.),
  • Body temperature exceeding 38°C,
  • Presence of skin issues in the area where the catheter will be inserted,
  • Undergoing chemotherapy treatment,
  • Unwillingness to voluntarily participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Closed System Peripheral Catheters
After the area where the catheter would be inserted was cleaned with an antiseptic solution and allowed to dry, a closed-system catheter was applied. Closed-system catheters are devices that allow access through needleless mechanisms, protecting the patient from accidental needle puncture injuries. They have mechanisms preventing blood leakage or pathogen entry.
Other: Closed-system catheter
Closed-system catheters was applied
No Intervention: Control
After the area where the catheter would be inserted was cleaned with an antiseptic solution and allowed to dry, a catheter was applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Identification Form
Time Frame: 1 day
he Patient Identification Form has been prepared by reviewing relevant literature. It consists of 27 questions, encompassing patient-specific information and catheter characteristics.
1 day
Daily Monitoring Form
Time Frame: 1 day
his form, comprised of 8 questions, has been designed to monitor patients on a daily basis, covering aspects such as catheter day, fluids administered, phlebitis score, infiltration score, skin characteristics, and signs of infection. Nurses used the Daily Monitoring Form to observe and record patient conditions on a daily basis.
1 day
Visual Infusion Phlebitis Assessment Scale, Staging Key - Peripheral IV'sVIPAS
Time Frame: 1 day
Developed by Alyce Schultze and Paulette Gallant, this scale was published by the Infusion Nurses Society in 2011 for the purpose of grading phlebitis. The scale involves observing the possible risks of the catheter during the administration of treatment through a peripheral intravenous catheter. It also includes grading the symptoms of phlebitis at each stage if phlebitis develops. The content validity index value of the scale was found to be 0.97
1 day
Pediatric peripheral intravenous infiltration assessment tool
Time Frame: 1 day
Pediatric peripheral intravenous infiltration assessment tool: Developed by Simona and evaluated for its psychometric properties, the Pediatric Peripheral Intravenous Infiltration Scale has undergone Turkish validity and reliability assessments by Temizsoy et al. (2017) and is suitable for use in newborns. Cohen kappa value of the scale was 0.80 (p<0.001) and Pearson correlation coefficient was r=0.95 (p<0.001). The Cronbach's alpha coefficient of the scale is 0.966, which shows that the level of infitration increases as the stages increase in the evaluation made in five stages.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tarsus University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 26, 2023

Primary Completion (Actual)

October 2, 2023

Study Completion (Actual)

October 2, 2023

Study Registration Dates

First Submitted

March 8, 2024

First Submitted That Met QC Criteria

March 8, 2024

First Posted (Actual)

March 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 1763831

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Catheter Infection

Clinical Trials on Closed-system catheter

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe